Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

COVID-19

The spread of novel betacoronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly escalated to a pandemic unseen for generations. With ramifications not before witnessed during peacetime, communication between healthcare professionals is more important than ever.

Multiple Myeloma

View all

Sorry, no posts matched your criteria.

CLL

View all

Sorry, no posts matched your criteria.

AML

View all
1:52
Impact of recent advancements in treatment of R/R AML on OS in clinical practice
Keri Maher • 9 Dec 2023
2:32
ISAL session highlights: gemtuzumab & small molecule inhibitors with chemotherapy in AML and APL
Alan Burnett • 21 Mar 2023

ALL

View all
4:21
Predicting outcomes for patients with leukemia and MDS after COVID-19 infection
Pinkal Desai • 11 Dec 2021
7:21
The impact of COVID-19 on ALL
Robin Foà • 24 Nov 2021

Lymphoma

View all
5:50
AEs physicians should look out for when treating R/R DLBCL with bispecific antibodies
Michael Dickinson • 7 Dec 2024
1:45
A Phase I/II trial of glofitamab monotherapy in R/R MCL
Tycel Phillips • 2 Jun 2024
5:04
Primary analysis of the ELM-2: odronextamab in heavily pretreated R/R FL
Michał Taszner • 26 Jun 2024
2:49
CD19 CAR-T therapy drives the expansion of clonal hematopoiesis and associated cytopenias in LBCL
Ash Alizadeh • 20 Dec 2023

Features

View all
VJSocial Media Masterclass - Social Media Strategy
VJSocial Media Masterclass - Engagement on Twitter
VJSocial Media Masterclass
iwCAR-T 2020 Presentations
The content of VJHemOnc is intended for healthcare professionals